Coloplast A/S (Coloplast) manufactures and sells products and offers services for ostomy care, respiratory, urology care, continence care, and skin and wound care. Its major products include urisheaths, ostomy bags, urine bags, catheters, anal irrigation systems, sling products, advanced foam dressings and hydrocolloid dressings for protection of skin and pressure injuries, cleansers, moisturizers, skin protectants, anti-fungal, and hand cleansers. The company offers its products under several brands, including SenSura, SpeediCath, Persiteen, Biatain, Conveen, InterDry, Brava, and Comfeel. Coloplast supplies its products through subsidiaries and distributors to hospitals, institutions, wholesalers, and retailers in Europe, Africa, South America, UAE, Singapore, Asia, Russia, Australia and North America. Coloplast is headquartered in Humlebaek, Denmark.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Coloplast AS
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Coloplast A/S Company Overview
- Coloplast A/S Company Snapshot
- Coloplast A/S Pipeline Products and Ongoing Clinical Trials Overview
- Coloplast A/S - Pipeline Analysis Overview
- Business Description
- Coloplast A/S - Key Facts
- Coloplast A/S - Major Products and Services
- Coloplast A/S Pipeline Products by Development Stage
- Coloplast A/S Ongoing Clinical Trials by Trial Status
- Coloplast A/S Pipeline Products Overview
- Biomedical Implant - Pelvic Organ Prolapse
- Biomedical Implant - Pelvic Organ Prolapse Product Overview
- CP308 Digital Ostomy Tool
- CP308 Digital Ostomy Tool Product Overview
- INTIBIA Implantable Tibial Nerve Stimulator
- INTIBIA Implantable Tibial Nerve Stimulator Product Overview
- INTIBIA Implantable Tibial Nerve Stimulator Clinical Trial
- Kerecis Omega3 - Battlefield Wounds
- Kerecis Omega3 - Battlefield Wounds Product Overview
- Kerecis Omega3 - Third-Degree Burns
- Kerecis Omega3 - Third-Degree Burns Product Overview
- Kerecis Omega3 Dura
- Kerecis Omega3 Dura Product Overview
- Kerecis Omega3 Hernia
- Kerecis Omega3 Hernia Product Overview
- Kerecis Omega3 Viruxide System
- Kerecis Omega3 Viruxide System Product Overview
- Kerecis Omega3 Viruxide System Clinical Trial
- Luja
- Luja Product Overview
- Ostomy Platform
- Ostomy Platform Product Overview
- Restorelle DirectFix Anterior Mesh
- Restorelle DirectFix Anterior Mesh Product Overview
- Restorelle DirectFix Anterior Mesh Clinical Trial
- SenSura Mio Convex Soft With Flex Coupling
- SenSura Mio Convex Soft With Flex Coupling Product Overview
- Sensuro Mio Stoma Baseplat
- Sensuro Mio Stoma Baseplat Product Overview
- Single-Use Compact Female Intermittent Catheter
- Single-Use Compact Female Intermittent Catheter Product Overview
- Coloplast A/S - Key Competitors
- Coloplast A/S - Key Employees
- Coloplast A/S - Key Employee Biographies
- Coloplast A/S - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Coloplast A/S, Recent Developments
- May 14, 2024: Kerecis to Present Scientific and Clinical Updates on Fish-Skin Grafts at the Symposium on Advanced Wound Care Spring
- May 14, 2024: Coloplast expands its Luja portfolio with next generation catheter for women
- May 07, 2024: Coloplast strengthens ostomy care portfolio with three significant product launches
- May 01, 2024: Kerecis to Provide Multiple Updates on its Medical-Fish-Skin Technology at the European Wound Management Association Meeting
- Apr 30, 2024: Coloplast Receives 510(K) Clearance For Folysil Silicone Catheter
- Apr 01, 2024: Coloplast Receives FDA 510(k) Clearance for Biatain Fiber Ag
- Feb 15, 2024: Medical-Fish-Skin Company Kerecis Expands Silicone Fish-Skin Combination Product Range
- Feb 09, 2024: Coloplast Announces Interim Financial Report, Q1 2023/24
- Nov 09, 2023: Coloplast Reports Annual Report 2022/23
- Nov 03, 2023: Clinical Consensus on Kerecis Fish-Skin Grafts to Be Presented at the SAWC Wound Conference
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Coloplast A/S Pipeline Products and Ongoing Clinical Trials Overview
- Coloplast A/S Pipeline Products by Equipment Type
- Coloplast A/S Pipeline Products by Indication
- Coloplast A/S Ongoing Clinical Trials by Trial Status
- Coloplast A/S, Key Facts
- Coloplast A/S, Major Products and Services
- Coloplast A/S Number of Pipeline Products by Development Stage
- Coloplast A/S Pipeline Products Summary by Development Stage
- Coloplast A/S Ongoing Clinical Trials by Trial Status
- Coloplast A/S Ongoing Clinical Trials Summary
- Biomedical Implant - Pelvic Organ Prolapse - Product Status
- Biomedical Implant - Pelvic Organ Prolapse - Product Description
- CP308 Digital Ostomy Tool - Product Status
- CP308 Digital Ostomy Tool - Product Description
- INTIBIA Implantable Tibial Nerve Stimulator - Product Status
- INTIBIA Implantable Tibial Nerve Stimulator - Product Description
- INTIBIA Implantable Tibial Nerve Stimulator - A Prospective, Randomized Clinical Trial Evaluating INTIBIA, an Investigational Implantable Tibial Nerve Stimulator, Through 24-Months (INTIBIA Pivotal Study IU024)
- Kerecis Omega3 - Battlefield Wounds - Product Status
- Kerecis Omega3 - Battlefield Wounds - Product Description
- Kerecis Omega3 - Third-Degree Burns - Product Status
- Kerecis Omega3 - Third-Degree Burns - Product Description
- Kerecis Omega3 Dura - Product Status
- Kerecis Omega3 Dura - Product Description
- Kerecis Omega3 Hernia - Product Status
- Kerecis Omega3 Hernia - Product Description
- Kerecis Omega3 Viruxide System - Product Status
- Kerecis Omega3 Viruxide System - Product Description
- Kerecis Omega3 Viruxide System - Study Evaluate the Efficacy of Kerecis Omega3 Viruxide System in COVID-19 Subjects
- Luja - Product Status
- Luja - Product Description
- Ostomy Platform - Product Status
- Ostomy Platform - Product Description
- Restorelle DirectFix Anterior Mesh - Product Status
- Restorelle DirectFix Anterior Mesh - Product Description
- Restorelle DirectFix Anterior Mesh - Real-Life Use of Transabdominal Restorelle Meshes in Apical Prolapse Repair: an Observational Post-Market Clinical Study
- SenSura Mio Convex Soft With Flex Coupling - Product Status
- SenSura Mio Convex Soft With Flex Coupling - Product Description
- Sensuro Mio Stoma Baseplat - Product Status
- Sensuro Mio Stoma Baseplat - Product Description
- Single-Use Compact Female Intermittent Catheter - Product Status
- Single-Use Compact Female Intermittent Catheter - Product Description
- Coloplast A/S, Key Employees
- Coloplast A/S, Key Employee Biographies
- Coloplast A/S, Subsidiaries
- Glossary
- Coloplast A/S Pipeline Products by Equipment Type
- Coloplast A/S Pipeline Products by Development Stage
- Coloplast A/S Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Rochester Medical Corporation
- B. Braun Melsungen AG
- GN Store Nord AS
- Smith & Nephew Plc
- Molnlycke Health Care AB
